{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:23:49Z","timestamp":1769084629112,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10072-024-07476-x","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T11:02:42Z","timestamp":1711105362000},"page":"3599-3609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of 123-I-MIBG cardiac scintigraphy in the differential diagnosis between dementia with Lewy bodies and Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-8766","authenticated-orcid":false,"given":"Giacomo","family":"Monzio Compagnoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildebrando","family":"Appollonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"7476_CR1","doi-asserted-by":"publisher","unstructured":"Bousiges O, Blanc F (2022) Biomarkers of dementia with Lewy bodies: differential diagnostic with Alzheimer\u2019s disease. Int J Mol Sci 23(12):6371. https:\/\/doi.org\/10.3390\/ijms23126371","DOI":"10.3390\/ijms23126371"},{"key":"7476_CR2","doi-asserted-by":"publisher","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J (2015) Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129(5):729\u2013748. https:\/\/doi.org\/10.1007\/s00401-015-1406-3","DOI":"10.1007\/s00401-015-1406-3"},{"key":"7476_CR3","doi-asserted-by":"publisher","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","DOI":"10.1212\/WNL.0000000000004058"},{"key":"7476_CR4","doi-asserted-by":"publisher","unstructured":"Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert M, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH (2021) Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol 20(6):484\u2013496. https:\/\/doi.org\/10.1016\/S1474-4422(21)00066-1","DOI":"10.1016\/S1474-4422(21)00066-1"},{"key":"7476_CR5","doi-asserted-by":"publisher","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Budd Haeberlein S, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"7476_CR6","doi-asserted-by":"publisher","unstructured":"Flotats A (2018) Role of myocardial 123I-mIBG innervation imaging in the diagnosis of neurodegenerative diseases. Clin Transl Imaging 6:449\u2013458. https:\/\/doi.org\/10.1007\/s40336-018-0306-7","DOI":"10.1007\/s40336-018-0306-7"},{"key":"7476_CR7","doi-asserted-by":"publisher","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, Consortium on DLB (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65(12):1863\u201372. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","DOI":"10.1212\/01.wnl.0000187889.17253.b1"},{"key":"7476_CR8","doi-asserted-by":"publisher","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O\u2019Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P, prodromal DLB Diagnostic Study Group (2020) Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 94(17):743\u2013755. https:\/\/doi.org\/10.1212\/WNL.0000000000009323","DOI":"10.1212\/WNL.0000000000009323"},{"key":"7476_CR9","doi-asserted-by":"publisher","unstructured":"Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, Tsuchiya K, Mori F, Wakabayashi K, Takahashi H (2005) Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 109(6):583\u2013588. https:\/\/doi.org\/10.1007\/s00401-005-0995-7","DOI":"10.1007\/s00401-005-0995-7"},{"key":"7476_CR10","doi-asserted-by":"publisher","unstructured":"King AE, Mintz J, Royall DR (2011) Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord 26(7):1218\u20131224. https:\/\/doi.org\/10.1002\/mds.23659","DOI":"10.1002\/mds.23659"},{"key":"7476_CR11","doi-asserted-by":"publisher","unstructured":"Watanabe H, Ieda T, Katayama T, Takeda A, Aiba I, Doyu M, Hirayama M, Sobue G (2001) Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 70(6):781\u2013783. https:\/\/doi.org\/10.1136\/jnnp.70.6.781","DOI":"10.1136\/jnnp.70.6.781"},{"key":"7476_CR12","doi-asserted-by":"publisher","unstructured":"Yoshita M, Taki J, Yamada M (2001) A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer\u2019s-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 71(5):583\u2013588. https:\/\/doi.org\/10.1136\/jnnp.71.5.583","DOI":"10.1136\/jnnp.71.5.583"},{"key":"7476_CR13","doi-asserted-by":"publisher","unstructured":"Oide T, Tokuda T, Momose M, Oguchi K, Nakamura A, Ohara S, Ikeda S (2003) Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer\u2019s disease and dementia with Lewy bodies. Intern Med 42(8):686\u2013690. https:\/\/doi.org\/10.2169\/internalmedicine.42.686","DOI":"10.2169\/internalmedicine.42.686"},{"key":"7476_CR14","doi-asserted-by":"publisher","unstructured":"Hanyu H, Shimizu S, Hirao K, Kanetaka H, Iwamoto T, Chikamori T, Usui Y, Yamashina A, Koizumi K, Abe K (2006) Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 33(3):248\u2013253. https:\/\/doi.org\/10.1007\/s00259-005-1921-x","DOI":"10.1007\/s00259-005-1921-x"},{"key":"7476_CR15","doi-asserted-by":"publisher","unstructured":"Yoshita M, Taki J, Yokoyama K, Noguchi-Shinohara M, Matsumoto Y, Nakajima K, Yamada M (2006) Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 66(12):1850\u20131854. https:\/\/doi.org\/10.1212\/01.wnl.0000219640.59984.a7","DOI":"10.1212\/01.wnl.0000219640.59984.a7"},{"key":"7476_CR16","doi-asserted-by":"publisher","unstructured":"Wada-Isoe K, Kitayama M, Nakaso K, Nakashima K (2007) Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study. J Neurol Sci 260(1\u20132):33\u201337. https:\/\/doi.org\/10.1016\/j.jns.2007.03.016","DOI":"10.1016\/j.jns.2007.03.016"},{"key":"7476_CR17","doi-asserted-by":"publisher","unstructured":"Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, El-Agnaf OMA, Yamada M (2009) CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer\u2019s disease. Brain Res 28(1251):1\u20136. https:\/\/doi.org\/10.1016\/j.brainres.2008.11.055","DOI":"10.1016\/j.brainres.2008.11.055"},{"key":"7476_CR18","doi-asserted-by":"publisher","unstructured":"Inui Y, Toyama H, Manabe Y, Sarai M, Iwata N (2014) Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer\u2019s disease. Ann Nucl Med 28(8):796\u2013804. https:\/\/doi.org\/10.1007\/s12149-014-0873-2","DOI":"10.1007\/s12149-014-0873-2"},{"key":"7476_CR19","doi-asserted-by":"publisher","unstructured":"Kim J, Park H, Oh Y, Song I, Yang D, Park J, Lee K (2015) (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer\u2019s disease. J Neurol Sci 357(1\u20132):173\u2013177. https:\/\/doi.org\/10.1016\/j.jns.2015.07.025","DOI":"10.1016\/j.jns.2015.07.025"},{"key":"7476_CR20","doi-asserted-by":"publisher","unstructured":"Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakajima K, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Samuraki M, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamasaki J, Yamashina S, Yamada M (2015) Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS One. 10(3):e0120540. https:\/\/doi.org\/10.1371\/journal.pone.0120540. (eCollection 2015)","DOI":"10.1371\/journal.pone.0120540"},{"key":"7476_CR21","doi-asserted-by":"publisher","unstructured":"Komatsu J, Samuraki M, Nakajima K, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamashina S, Yamasaki J, Yoshita M, Yamada M (2018) 123I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study. Neurol Neurosurg Psychiatry 89(11):1167\u20131173. https:\/\/doi.org\/10.1136\/jnnp-2017-317398","DOI":"10.1136\/jnnp-2017-317398"},{"key":"7476_CR22","doi-asserted-by":"publisher","unstructured":"Shimizu S, Hirao K, Kanetaka H, Namioka N, Hatanaka H, Hirose D, Fukasawa R, Umahara T, Sakurai H, Hanyu H (2016) Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 43(1):184\u2013192. https:\/\/doi.org\/10.1007\/s00259-015-3146-y","DOI":"10.1007\/s00259-015-3146-y"},{"key":"7476_CR23","doi-asserted-by":"publisher","unstructured":"Abbasi M, Ghalandari N, Farzanefar S, Aghamollaii V, Ahmadi M, Ganji M, Afarideh M, Loloee S, Naseri M, Tafakhori A (2017) Potential diagnostic value of 131I-MIBG myocardial scintigraphy in discrimination between Alzheimer disease and dementia with Lewy bodies. Clin Neurol Neurosurg 163:163\u2013166. https:\/\/doi.org\/10.1016\/j.clineuro.2017.10.024","DOI":"10.1016\/j.clineuro.2017.10.024"},{"key":"7476_CR24","doi-asserted-by":"publisher","unstructured":"Kane JPM, Roberts G, Petrides GS, Lloyd JJ, O\u2019Brien JT, Thomas AJ (2019) 123I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort. Parkinsonism Relat Disord 62:79\u201384. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.01.024","DOI":"10.1016\/j.parkreldis.2019.01.024"},{"issue":"9","key":"7476_CR25","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1007\/s00259-008-0828-8","volume":"35","author":"M Estorch","year":"2008","unstructured":"Estorch M, Camacho V, Paredes P, Rivera E, Rodr\u00edguez-Revuelto A, Flotats A, Kulisevsky J, Carrio I (2008) Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging 35(9):1636\u20131641. https:\/\/doi.org\/10.1007\/s00259-008-0828-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7476_CR26","doi-asserted-by":"publisher","unstructured":"Treglia G, Cason E, Cortelli P, Gabellini A, Liguori R, Bagnato A, Giordano A, Fagioli G (2014) Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? J Neuroimaging. 24(2):149\u201354. https:\/\/doi.org\/10.1111\/j.1552-6569.2012.00774.x","DOI":"10.1111\/j.1552-6569.2012.00774.x"},{"key":"7476_CR27","doi-asserted-by":"publisher","unstructured":"Slaets S, Van Acker F, Versijpt J, Hauth L, Goeman J, Martin J, De Deyn PP, Engelborghs S (2015) Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. Int J Geriatr Psychiatry 30(8):864\u2013869. https:\/\/doi.org\/10.1002\/gps.4229","DOI":"10.1002\/gps.4229"},{"key":"7476_CR28","doi-asserted-by":"publisher","unstructured":"Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C, SCILLA Working Group (2016) (123) I-2\u03b2-carbomethoxy-3\u03b2-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: a comparative study. Ann Neurol. 80(3):368\u201378. https:\/\/doi.org\/10.1002\/ana.24717","DOI":"10.1002\/ana.24717"},{"key":"7476_CR29","doi-asserted-by":"publisher","unstructured":"Sakamoto F, Shiraishi S, Tsuda N, Hashimoto M, Tomiguchi S, Ikeda M, Yamashita Y (2017) Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features? Br J Radiol 90(1070):20160156. https:\/\/doi.org\/10.1259\/bjr.20160156","DOI":"10.1259\/bjr.20160156"},{"key":"7476_CR30","doi-asserted-by":"publisher","unstructured":"Sakamoto F, Shiraishi S, Yoshida M, Tomiguchi S, Hirai T, Namimoto T, Hashimoto M, Ikeda M, Uetani H, Yamashita Y (2014) Diagnosis of dementia with Lewy bodies: diagnostic performance of combined 123I-IMP brain perfusion SPECT and 123I-MIBG myocardial scintigraphy. Ann Nucl Med 28(3):203\u2013211. https:\/\/doi.org\/10.1007\/s12149-013-0796-3","DOI":"10.1007\/s12149-013-0796-3"},{"key":"7476_CR31","doi-asserted-by":"publisher","unstructured":"Manabe Y, Inui Y, Toyama H, Kosaka K (2017) 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies. Psychiatry Res Neuroimaging 30(261):75\u201379. https:\/\/doi.org\/10.1016\/j.pscychresns.2016.12.011","DOI":"10.1016\/j.pscychresns.2016.12.011"},{"key":"7476_CR32","doi-asserted-by":"publisher","unstructured":"Roberts G, Durcan R, Donaghy PC, Lawley S, Ciafone J, Hamilton CA, Colloby SJ, Firbank MJ, Allan L, Barnett N, Barker S, Howe K, Ali T, Petrides GS, Lloyd J, Taylor J, O\u2019Brien J, Thomas AJ (2021) Accuracy of cardiac innervation scintigraphy for mild cognitive impairment with Lewy bodies. Neurology 96(23):e2801\u2013e2811. https:\/\/doi.org\/10.1212\/WNL.0000000000012060","DOI":"10.1212\/WNL.0000000000012060"},{"key":"7476_CR33","doi-asserted-by":"publisher","unstructured":"Treglia G, Cason E (2012) Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with Lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging 22(2):111\u2013117. https:\/\/doi.org\/10.1111\/j.1552-6569.2010.00532.x","DOI":"10.1111\/j.1552-6569.2010.00532.x"},{"key":"7476_CR34","doi-asserted-by":"publisher","unstructured":"Nihashi T, Ito K, Terasawa T (2020) Diagnostic accuracy of DAT-SPECT and MIBG scintigraphy for dementia with Lewy bodies: an updated systematic review and Bayesian latent class model meta-analysis. Eur J Nucl Med Mol Imaging 47(8):1984\u20131997. https:\/\/doi.org\/10.1007\/s00259-019-04480-8","DOI":"10.1007\/s00259-019-04480-8"},{"key":"7476_CR35","doi-asserted-by":"publisher","unstructured":"Mishima A, Nihashi T, Ando Y, Kawai H, Kato T, Ito K, Terasawa T (2016) Biomarkers differentiating dementia with Lewy bodies from other dementias: a meta-analysis. J Alzheimers Dis 50(1):161\u2013174. https:\/\/doi.org\/10.3233\/JAD-150675","DOI":"10.3233\/JAD-150675"},{"key":"7476_CR36","doi-asserted-by":"publisher","unstructured":"Sonni I, Ratib O, Boccardi M, Picco A, Herholz K, Nobili F, Varrone A, Geneva Task Force for the Roadmap of Alzheimer\u2019s Biomarkers (2017) Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer\u2019s disease and dementia with Lewy bodies in the context of a structured 5-phase development framework. Neurobiol Aging. 52:228\u2013242. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.04.026","DOI":"10.1016\/j.neurobiolaging.2016.04.026"},{"key":"7476_CR37","doi-asserted-by":"publisher","unstructured":"Flotats A, Carri\u00f3 I, Agostini D, Le Guludec D, Marcassa C, Sch\u00e4fers M, Somsen GA, Unlu M, Verberne HJ, EANM Cardiovascular Committee; European Council of Nuclear Cardiology (2010) Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 37(9):1802\u201312. https:\/\/doi.org\/10.1007\/s00259-010-1491-4","DOI":"10.1007\/s00259-010-1491-4"},{"key":"7476_CR38","doi-asserted-by":"publisher","unstructured":"Jacobson AF, Travin MI (2015) Impact of medications on mIBG uptake, with specific attention to the heart: comprehensive review of the literature. J Nucl Cardiol 22(5):980\u2013993. https:\/\/doi.org\/10.1007\/s12350-015-0170-z","DOI":"10.1007\/s12350-015-0170-z"},{"key":"7476_CR39","doi-asserted-by":"publisher","unstructured":"Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE (1992) A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13(7):513\u2013521. https:\/\/doi.org\/10.1097\/00006231-199207000-00006","DOI":"10.1097\/00006231-199207000-00006"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07476-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T04:11:59Z","timestamp":1721189519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07476-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7476"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07476-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}